- Highlights
- Cachexia, a syndrome marked by unwanted weight loss, sickness, and loss of appetite that accompanies and amplifies chronic illness, affects roughly half of all cancer patients and is responsible for a quarter of all cancer deaths
- Incoming Salk professor discovers that some lung cancer tumors can induce cachexia by communicating directly with the brain using a lipid signaling molecule—hijacking the nervous system and impacting behavior
- Findings suggest that tumors affect the peripheral nervous system and dietary changes could be used to treat cachexia and improve outcomes in lung cancer patients
LA JOLLA—According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle and fat loss, reducing quality of life and sometimes even limiting treatment options. A new study led by
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
